BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 25026296)

  • 21. Downregulation of COX-2 and CYP 4A signaling by isoliquiritigenin inhibits human breast cancer metastasis through preventing anoikis resistance, migration and invasion.
    Zheng H; Li Y; Wang Y; Zhao H; Zhang J; Chai H; Tang T; Yue J; Guo AM; Yang J
    Toxicol Appl Pharmacol; 2014 Oct; 280(1):10-20. PubMed ID: 25094029
    [TBL] [Abstract][Full Text] [Related]  

  • 22. miRNA expression patterns in chemoresistant breast cancer tissues.
    Lv J; Xia K; Xu P; Sun E; Ma J; Gao S; Zhou Q; Zhang M; Wang F; Chen F; Zhou P; Fu Z; Xie H
    Biomed Pharmacother; 2014 Oct; 68(8):935-42. PubMed ID: 25451164
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Upregulation of miR-129-5p increases the sensitivity to Taxol through inhibiting HMGB1-mediated cell autophagy in breast cancer MCF-7 cells.
    Shi Y; Gong W; Lu L; Wang Y; Ren J
    Braz J Med Biol Res; 2019; 52(11):e8657. PubMed ID: 31664305
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA-137 inhibits autophagy and chemosensitizes pancreatic cancer cells by targeting ATG5.
    Wang ZC; Huang FZ; Xu HB; Sun JC; Wang CF
    Int J Biochem Cell Biol; 2019 Jun; 111():63-71. PubMed ID: 30710750
    [TBL] [Abstract][Full Text] [Related]  

  • 25. miR-218 targets survivin and regulates resistance to chemotherapeutics in breast cancer.
    Hu Y; Xu K; Yagüe E
    Breast Cancer Res Treat; 2015 Jun; 151(2):269-80. PubMed ID: 25900794
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Resveratrol chemosensitizes adriamycin-resistant breast cancer cells by modulating miR-122-5p.
    Zhang W; Jiang H; Chen Y; Ren F
    J Cell Biochem; 2019 Sep; 120(9):16283-16292. PubMed ID: 31155753
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Isoliquiritigenin inhibits proliferation and metastasis of MKN28 gastric cancer cells by suppressing the PI3K/AKT/mTOR signaling pathway.
    Zhang XR; Wang SY; Sun W; Wei C
    Mol Med Rep; 2018 Sep; 18(3):3429-3436. PubMed ID: 30066879
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dual-Targeting of miR-124-3p and ABCC4 Promotes Sensitivity to Adriamycin in Breast Cancer Cells.
    Hu D; Li M; Su J; Miao K; Qiu X
    Genet Test Mol Biomarkers; 2019 Mar; 23(3):156-165. PubMed ID: 30807260
    [TBL] [Abstract][Full Text] [Related]  

  • 29. miR-222 induces Adriamycin resistance in breast cancer through PTEN/Akt/p27
    Wang DD; Yang SJ; Chen X; Shen HY; Luo LJ; Zhang XH; Zhong SL; Zhao JH; Tang JH
    Tumour Biol; 2016 Nov; 37(11):15315-15324. PubMed ID: 27699665
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isoliquiritigenin Induces Autophagy and Inhibits Ovarian Cancer Cell Growth.
    Chen HY; Huang TC; Shieh TM; Wu CH; Lin LC; Hsia SM
    Int J Mol Sci; 2017 Sep; 18(10):. PubMed ID: 28934130
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemotherapy-Induced Extracellular Vesicle miRNAs Promote Breast Cancer Stemness by Targeting
    Shen M; Dong C; Ruan X; Yan W; Cao M; Pizzo D; Wu X; Yang L; Liu L; Ren X; Wang SE
    Cancer Res; 2019 Jul; 79(14):3608-3621. PubMed ID: 31118200
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Suppression of SPIN1-mediated PI3K-Akt pathway by miR-489 increases chemosensitivity in breast cancer.
    Chen X; Wang YW; Xing AY; Xiang S; Shi DB; Liu L; Li YX; Gao P
    J Pathol; 2016 Aug; 239(4):459-72. PubMed ID: 27171498
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA-132 and microRNA-212 mediate doxorubicin resistance by down-regulating the PTEN-AKT/NF-κB signaling pathway in breast cancer.
    Xie M; Fu Z; Cao J; Liu Y; Wu J; Li Q; Chen Y
    Biomed Pharmacother; 2018 Jun; 102():286-294. PubMed ID: 29567542
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MiR-487a resensitizes mitoxantrone (MX)-resistant breast cancer cells (MCF-7/MX) to MX by targeting breast cancer resistance protein (BCRP/ABCG2).
    Ma MT; He M; Wang Y; Jiao XY; Zhao L; Bai XF; Yu ZJ; Wu HZ; Sun ML; Song ZG; Wei MJ
    Cancer Lett; 2013 Oct; 339(1):107-15. PubMed ID: 23879965
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased fucosylation has a pivotal role in multidrug resistance of breast cancer cells through miR-224-3p targeting FUT4.
    Feng X; Zhao L; Gao S; Song X; Dong W; Zhao Y; Zhou H; Cheng L; Miao X; Jia L
    Gene; 2016 Mar; 578(2):232-41. PubMed ID: 26701615
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The c-Myc/miR-27b-3p/ATG10 regulatory axis regulates chemoresistance in colorectal cancer.
    Sun W; Li J; Zhou L; Han J; Liu R; Zhang H; Ning T; Gao Z; Liu B; Chen X; Ba Y
    Theranostics; 2020; 10(5):1981-1996. PubMed ID: 32104496
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-125b upregulation confers aromatase inhibitor resistance and is a novel marker of poor prognosis in breast cancer.
    Vilquin P; Donini CF; Villedieu M; Grisard E; Corbo L; Bachelot T; Vendrell JA; Cohen PA
    Breast Cancer Res; 2015 Jan; 17(1):13. PubMed ID: 25633049
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA-1 overexpression increases chemosensitivity of non-small cell lung cancer cells by inhibiting autophagy related 3-mediated autophagy.
    Hua L; Zhu G; Wei J
    Cell Biol Int; 2018 Sep; 42(9):1240-1249. PubMed ID: 29851226
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MKNK2 enhances chemoresistance of ovarian cancer by suppressing autophagy via miR-125b.
    Wang J; Da C; Su Y; Song R; Bai Z
    Biochem Biophys Res Commun; 2021 Jun; 556():31-38. PubMed ID: 33836345
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Isoliquiritigenin inhibits the proliferation, apoptosis and migration of osteosarcoma cells.
    Li C; Zhou X; Sun C; Liu X; Shi X; Wu S
    Oncol Rep; 2019 Apr; 41(4):2502-2510. PubMed ID: 30720124
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.